Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890879185> ?p ?o ?g. }
- W2890879185 endingPage "6009" @default.
- W2890879185 startingPage "6009" @default.
- W2890879185 abstract "6009Background: A minority of patients with metastatic HNSCC respond to the anti-programmed death (PD-1) monoclonal antibody, Nivolumab (Nivo). We sought to determine whether targeted radiation to a single lesion combined with Nivo would enhance tumor regression in non-irradiated lesions (abscopal response) and improve outcomes. Methods: Patients with M1 HNSCC (including nasopharynx) with at least two RECIST 1.1 measurable lesions were randomized with stratification for viral status (EBV/HPV pos vs. neg) 1:1 to either Nivo alone q 2 weeks or Nivo with SBRT to a single lesion (9 Gy x 3) between the 1st and 2nd doses of Nivo. The primary end-point was objective response rate (ORR) in non-irradiated lesions using RECIST 1.1. Secondary analyses included overall survival (OS), progression free-survival (PFS), and duration-of-response (DOR). We hypothesized that SBRT added to Nivo would increase ORR from 15% to 45%. Enrolling 53 patients thus provides a one-sided alpha of 0.10 and a power of 0.80. Results: 53 p..." @default.
- W2890879185 created "2018-09-27" @default.
- W2890879185 creator A5002723616 @default.
- W2890879185 creator A5005775817 @default.
- W2890879185 creator A5012145979 @default.
- W2890879185 creator A5026148495 @default.
- W2890879185 creator A5026256296 @default.
- W2890879185 creator A5027048828 @default.
- W2890879185 creator A5027280876 @default.
- W2890879185 creator A5034787589 @default.
- W2890879185 creator A5036572642 @default.
- W2890879185 creator A5048368191 @default.
- W2890879185 creator A5049696010 @default.
- W2890879185 creator A5052154004 @default.
- W2890879185 creator A5052610122 @default.
- W2890879185 creator A5061365371 @default.
- W2890879185 creator A5075299423 @default.
- W2890879185 creator A5079162702 @default.
- W2890879185 creator A5089724606 @default.
- W2890879185 date "2018-05-20" @default.
- W2890879185 modified "2023-10-12" @default.
- W2890879185 title "A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)." @default.
- W2890879185 doi "https://doi.org/10.1200/jco.2018.36.15_suppl.6009" @default.
- W2890879185 hasPublicationYear "2018" @default.
- W2890879185 type Work @default.
- W2890879185 sameAs 2890879185 @default.
- W2890879185 citedByCount "44" @default.
- W2890879185 countsByYear W28908791852018 @default.
- W2890879185 countsByYear W28908791852019 @default.
- W2890879185 countsByYear W28908791852020 @default.
- W2890879185 countsByYear W28908791852021 @default.
- W2890879185 countsByYear W28908791852022 @default.
- W2890879185 crossrefType "journal-article" @default.
- W2890879185 hasAuthorship W2890879185A5002723616 @default.
- W2890879185 hasAuthorship W2890879185A5005775817 @default.
- W2890879185 hasAuthorship W2890879185A5012145979 @default.
- W2890879185 hasAuthorship W2890879185A5026148495 @default.
- W2890879185 hasAuthorship W2890879185A5026256296 @default.
- W2890879185 hasAuthorship W2890879185A5027048828 @default.
- W2890879185 hasAuthorship W2890879185A5027280876 @default.
- W2890879185 hasAuthorship W2890879185A5034787589 @default.
- W2890879185 hasAuthorship W2890879185A5036572642 @default.
- W2890879185 hasAuthorship W2890879185A5048368191 @default.
- W2890879185 hasAuthorship W2890879185A5049696010 @default.
- W2890879185 hasAuthorship W2890879185A5052154004 @default.
- W2890879185 hasAuthorship W2890879185A5052610122 @default.
- W2890879185 hasAuthorship W2890879185A5061365371 @default.
- W2890879185 hasAuthorship W2890879185A5075299423 @default.
- W2890879185 hasAuthorship W2890879185A5079162702 @default.
- W2890879185 hasAuthorship W2890879185A5089724606 @default.
- W2890879185 hasConcept C121608353 @default.
- W2890879185 hasConcept C126322002 @default.
- W2890879185 hasConcept C143998085 @default.
- W2890879185 hasConcept C168563851 @default.
- W2890879185 hasConcept C203092338 @default.
- W2890879185 hasConcept C2776530083 @default.
- W2890879185 hasConcept C2776833033 @default.
- W2890879185 hasConcept C2777701055 @default.
- W2890879185 hasConcept C2779984678 @default.
- W2890879185 hasConcept C2780030458 @default.
- W2890879185 hasConcept C2780400711 @default.
- W2890879185 hasConcept C2781274730 @default.
- W2890879185 hasConcept C2781464078 @default.
- W2890879185 hasConcept C31760486 @default.
- W2890879185 hasConcept C500558357 @default.
- W2890879185 hasConcept C509974204 @default.
- W2890879185 hasConcept C535046627 @default.
- W2890879185 hasConcept C71924100 @default.
- W2890879185 hasConceptScore W2890879185C121608353 @default.
- W2890879185 hasConceptScore W2890879185C126322002 @default.
- W2890879185 hasConceptScore W2890879185C143998085 @default.
- W2890879185 hasConceptScore W2890879185C168563851 @default.
- W2890879185 hasConceptScore W2890879185C203092338 @default.
- W2890879185 hasConceptScore W2890879185C2776530083 @default.
- W2890879185 hasConceptScore W2890879185C2776833033 @default.
- W2890879185 hasConceptScore W2890879185C2777701055 @default.
- W2890879185 hasConceptScore W2890879185C2779984678 @default.
- W2890879185 hasConceptScore W2890879185C2780030458 @default.
- W2890879185 hasConceptScore W2890879185C2780400711 @default.
- W2890879185 hasConceptScore W2890879185C2781274730 @default.
- W2890879185 hasConceptScore W2890879185C2781464078 @default.
- W2890879185 hasConceptScore W2890879185C31760486 @default.
- W2890879185 hasConceptScore W2890879185C500558357 @default.
- W2890879185 hasConceptScore W2890879185C509974204 @default.
- W2890879185 hasConceptScore W2890879185C535046627 @default.
- W2890879185 hasConceptScore W2890879185C71924100 @default.
- W2890879185 hasIssue "15_suppl" @default.
- W2890879185 hasLocation W28908791851 @default.
- W2890879185 hasOpenAccess W2890879185 @default.
- W2890879185 hasPrimaryLocation W28908791851 @default.
- W2890879185 hasRelatedWork W1999020268 @default.
- W2890879185 hasRelatedWork W2022208959 @default.
- W2890879185 hasRelatedWork W2025421597 @default.
- W2890879185 hasRelatedWork W2032166347 @default.
- W2890879185 hasRelatedWork W2052727153 @default.
- W2890879185 hasRelatedWork W2108789863 @default.
- W2890879185 hasRelatedWork W2112845420 @default.
- W2890879185 hasRelatedWork W2117878645 @default.